Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pivalate SCHEMBL9952824 | 0.81 | ACP3 (0.53) | CES2MEN1KMT2AMAPTMAOB | |
| Hydrochloric Acid SCHEMBL1453353 | 0.81 | TSHR (0.52) | CES2MAPTNPSR1ALDH1A1MAOB | |
| Bromide SCHEMBL1504916 | 0.81 | TSHR (0.52) | CES2MAPTNPSR1ALDH1A1MGLL | |
| SCHEMBL1626915 | 0.77 | APP (0.55) | CES2MEN1KMT2AMAPTSRD5A2 | |
| SCHEMBL14815251 | 0.75 | CES2 (0.52) | CES2MEN1KMT2AMAPTSRD5A2 | |
| SCHEMBL9584756 | 0.75 | CES2 (0.52) | CES2MEN1KMT2AMAPTSRD5A2 | |
| SCHEMBL382497 | 0.74 | CYP1A2 (0.59) | CES2MEN1KMT2AMAPTSRD5A2 | |
| SCHEMBL30605754 | 0.74 | CYP1A2 (0.59) | CES2MEN1KMT2AMAPTSRD5A2 | |
| SCHEMBL715409 | 0.74 | CYP1A2 (0.59) | CES2MEN1KMT2AMAPTSRD5A2 | |
| SCHEMBL389210 | 0.74 | CES2 (0.50) | CES2MEN1KMT2AMAPTSRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2655382-B1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) | 2022-09-28 | — | — | EP | disclosed |
| US-9273070-B2 | Organozinc complexes and processes for making and using the same | KNOCHEL PAUL (DE) | 2016-03-01 | — | — | US | disclosed |
| US-20140031545-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | LUDWIG-MAXIMILIAN-UNIVERSITAT MUNCHEN (DE) | 2014-01-30 | — | — | US | disclosed |
| EP-2655382-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | Ludwig-Maximilians-Universität München (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012085168-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2012-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140031545-A1 | ORGANOZINC COMPLEXES AND PROCESSES FOR MAKING AND USING THE SAME | ODC1, AOC1, ADH1C | CES2 2671/4885MEN1 673/4885KMT2A 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.